Jan Gesenberg

Jan Gesenberg

Auto-generated profile, based on publicly available information

Jan Gesenberg

Department of Cardiology, Heartcentre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany; Institute for Heart and Circulation Research, University Cologne, Cologne, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2017 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MMMartin Mollenhauer
Martin Mollenhauer
KFKai Friedrichs
Kai Friedrichs
MLMax Lange
Max Lange
JGJan Gesenberg
Jan Gesenberg
LRLisa Remane
Lisa Remane
VRVolker Rudolph
Volker Rudolph
Rationale:: Ventricular arrhythmias remain the leading cause of death in patients suffering myocardial ischemia. Myeloperoxidase, a heme enzyme released by polymorphonuclear neutrophils, accumulates within ischemic myocardium and has been linked to adverse left ventricular remodeling. Objective:: To reveal the role of myeloperoxidase for the development of ventricular arrhythmias. Methods and Results:: In different murine models of myocardial ischemia, myeloperoxidase deficiency profoundly decreased vulnerability for ventricular tachycardia on programmed right ventricular and burst stimulation and spontaneously as assessed by ECG telemetry after isoproterenol injection. Experiments using CD11b/CD18 integrin–deficient (CD11b −/− ) mice and intravenous myeloperoxidase infusion revealed that neutrophil infiltration is a prerequisite for myocardial myeloperoxidase accumulation. Ventricles from myeloperoxidase-deficient (Mpo −/− ) mice showed less pronounced slowing and decreased heterogeneity of electric conduction in the peri-infarct zone than wild-type mice. Expression of the redox-sensitive gap junctional protein Cx43 (Connexin 43) was reduced in the peri-infarct area of wild-type compared with Mpo −/− mice. In isolated wild-type cardiomyocytes, Cx43 protein content decreased on myeloperoxidase/H 2 O 2 incubation. Mapping of induced pluripotent stem cell–derived cardiomyocyte networks and in vivo investigations linked Cx43 breakdown to myeloperoxidase-dependent activation of matrix metalloproteinase 7. Moreover, Mpo −/− mice showed decreased ventricular postischemic fibrosis reflecting reduced accumulation of myofibroblasts. Ex vivo, myeloperoxidase was demonstrated to induce fibroblast-to-myofibroblast transdifferentiation by activation of p38 mitogen-activated protein kinases resulting in upregulated collagen generation. In support of our experimental findings, baseline myeloperoxidase plasma levels were independently associated with a history of ventricular arrhythmias, sudden cardiac death, or implantable cardioverter–defibrillator implantation in a cohort of 2622 stable patients with an ejection fraction >35% undergoing elective diagnostic cardiac evaluation. Conclusions:: Myeloperoxidase emerges as a crucial mediator of postischemic myocardial remodeling and may evolve as a novel pharmacological target for secondary disease prevention after myocardial ischemia.

1 May 2020 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
JGJan-Erik Guelker
Jan-Erik Guelker
ABAlexander Bufe
Alexander Bufe
CBChristian Blockhaus
Christian Blockhaus
JGJan Gesenberg
Jan Gesenberg
JKJulian Kuervers
Julian Kuervers
KMKambis Mashayekhi
Kambis Mashayekhi